Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Endocrine 1

Conditions

Polycystic Ovary Syndrome 2Recurrence 1Prolactinoma 1Pituitary Neoplasms 1Ovarian Hyperstimulation Syndrome 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × Cabergoline × Clear all
NCT07168837 2025-09-11

Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction

Al-Azhar University

Phase NA Completed
100 enrolled

Polycystic Ovary Syndrome

NCT03457389 2020-03-18

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Seoul National University Hospital

Phase NA Unknown
68 enrolled
Endocrine

Pituitary Neoplasms, Recurrence, Prolactinoma

NCT01569256 2012-04-04

Ovarian Hyperstimulation Syndrome and Cabergoline

Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

Phase NA Completed
40 enrolled
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡